Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)

Clinical trial NCT06189742 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06189742
Sponsor: Dr. Anne Ellis
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma With Allergic Rhinitis

Start date: 2024-01-29
Primary completion: 2026-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.